Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-390,957 in Premature Ejaculation
NCT00143117Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in premature ejaculation (PE) comparing UK-390,957 with Placebo (2 arms). Primary endpoint: Assessment of efficacy and safety. Started Aug 2004; status: completed.
02
Drugs
UK-390957
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT00143117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143117.